Molecular Characterization of Carbapenemase-Producing Enterobacterales
NCT07116356 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-08-11
Summary
Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Antibiotic administration
different samples were collected from patients admitted at oncology center at sohag
- DIAGNOSTIC_TEST
-
Molecular detection of antibiotic resistance
Molecular detection of carbapenem resistant genes: * Extraction of nucleic acid from isolated organisms by boiling. * Primers will be used for detection of carbaenem resistant genes
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 4 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-10
- Primary Completion
- 2025-09-30
- Completion
- 2026-02-20
Countries
- Egypt
Study Locations
More Related Trials
-
Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients
NCT07118384 ·Status: RECRUITING ·Phase: NA
-
A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021
NCT05762094 ·Status: UNKNOWN
-
Efficacy and Safety of Colistin Based Antibiotic Therapy
NCT04764058 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Switch to Oral Antibiotics in Gram-negative Bacteremia
NCT04146922 ·Status: COMPLETED ·Phase: NA
-
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
NCT03397914 ·Status: COMPLETED ·Phase: PHASE4
-
Type VI Secretion System in Klebsiella Pneumoniae
NCT05516654 ·Status: UNKNOWN
-
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362 ·Status: COMPLETED
-
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
NCT04876430 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis
NCT04552210 ·Status: UNKNOWN
-
Catheter Related - Gram Positive Bloodstream Infections
NCT00467272 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections
NCT01314053 ·Status: UNKNOWN
-
Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
NCT02988414 ·Status: COMPLETED
-
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT04434300 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Clinical Use of Polymyxin B
NCT02682355 ·Status: COMPLETED
-
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
NCT04671290 ·Status: COMPLETED
-
Safety and Efficacy Study of High Dose Colistin
NCT02162966 ·Status: UNKNOWN ·Phase: PHASE4
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA
-
Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR
NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia
NCT01737320 ·Status: COMPLETED ·Phase: NA
-
The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
NCT03950544 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.
NCT03680898 ·Status: UNKNOWN ·Phase: NA
-
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
NCT06422533 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis
NCT06963853 ·Status: RECRUITING
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN